Safety and immunogenicity of measles–mumps–rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome) (Q60695313)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Eleonora Gambineri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Maria Moriondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Massimo Resti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Letizia Betti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Lucien Rojas Saldias

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alberto Vierucci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Anna M G Gelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1668-1671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

A deletion in chromosome 22 can cause DiGeorge syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Role of the thymus in humoral immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Measles in Europe in 2001-2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

MMR vaccine in HIV-infected children -- potential hazards?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Vaccine-associated measles pneumonitis in an adult with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.005

10.1016/J.VACCINE.2004.10.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705470%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference